(NAR) VOL. 23 NO. 1, JANUARY - MARCH 2012)
a. To strengthen measles case-based surveillance
b. To strengthen detection of rubella cases through measles surveillance and laboratory confirmation
c. To evaluate impact of the measles and rubella routine and supplemental immunization activities in interrupting measles transmission and achieving control of rubella through efficient laboratory confirmation
d. To establish the use of dried blood spot (BDS) and nasopharyngeal swab (NPS) as other methods of confirming suspect cases
e. To implement standards for the collection, handling, storage and transport of DBS and NPS samples
CASE INVESTIGATION FORM (CIF) - |
| - Refers to reporting form that allows collection of standard information to acquire epidemiological study of disease incidence and disease patterns |
CLUSTER |
| Defined as two or more persons presenting with manifestations of a suspect measles case that are detected with onset of illness within a period of 7 to 21 days and in the same geographical area and/or are epidemiologically linked |
CONTACTS |
| Are all persons living in a household of other close quarters with the case during the infectious period (5 days before to 5 days after the onset of rash) |
DISEASE REPORTING UNIT | (DRU) This includes all health facilities (rural health units, hospitals, laboratories, seaports and airport are considered DRUs) | |
EPIDEMIOLOGICALLY-LINKED MEASLES CASE | Defined as a suspected measles case who was not discarded and who: | |
- had contact with a laboratory confirmed case or another epidemiologically-linked case within 7-21 days before rash onset and | ||
- the other epidemiologically-linked or laboratory confirmed case was infectious at the time of contact (i.e. contact was 5 days before and 5 days after rash onset) | ||
IMMUNOGLOBULIN CLASS M (IgM) | An antibody detected to confirm suspect measles cases | |
PROVINCIAL EPIDEMIOLOGY AND SURVEILLANCE UNIT (PESU) | Refers to the unit established in the Provincial Health Offices that provides services on public health surveillance and epidemiology | |
PHILIPPINE INTEGRATED DISEASE SURVEILLANCE AND RESPONSE (PIDSR) |
| Refers to the Philippines process of coordination, prioritizing, and streamlining of core surveillance activities (e.g., data collection, reporting, laboratory and epidemiological confirmation, analysis and feedback), support functions (e.g., training, monitoring, financial and logistics) and response (e.g.. epidemic investigation) with the aim of making the system more efficient and effective in providing timely, accurate and relevant information for action |
REGIONAL EPIDEMIOLOGY AND SURVEILLANCE UNIT (RESU) | Refers to the unit established in the Centers for Health Development or the DOH regional offices that provide services on public health surveillance and epidemiolog | |
RESEARCH INSTITUTE FOR TROPICAL MEDICINE (RITM) | It houses the Department of Virology which is the national measles reference laboratory | |
RURAL HEALTH UNIT (RHU) | Refers to the unit established in the rural health units that provides services on public health surveillance and epidemiology | |
SUSPECTED MEASLES CASE | Any individual, regardless of age, with history of fever (38°C or more) or hot to touch, generalized non-vesicular rash of 3 or more days duration; and at least one of the following cough, coryza, or conjunctivitis |
A. Laboratory Procedures for Case Confirmation1. Use of Serum Samples for IgM testing
A single serum sample obtained at the first contact with the patient at any time within 28 days after rash onset shall be taken from ALL suspected measles cases. Serum sample collection remains the GOLD STANDARD for confirming suspect cases under surveillance. measles-specific IgM antibodies appear within the first few days of rash onset and decline rapidly after one month. Specimen shall be sent to RITM within 72 hours after collection with the completely filled-up measles Case Investigation Form (Annex A.).
Provided that the epidemiological linkage among cases has been established within a household, specimen shall be taken from the index case (first person that fit the case definition of suspected measles case).
In line with this, it is very important to identify accurate information regarding the exposure history of suspect measles case. The CIF shall contain basic epidemiological information on time, date, place and history of contact with a known measles case. This will help identify origin and path of measles virus transmission.
Patients admitted at hospital facilities and those DRUs (RHU/Health Centers) that have the capacity to collect, store and transport shall have serum sample collected. Procedures for collection, storage and transport of sample are contained in the Annex B..
2. Use of alternative sample (dried blood spot )
Dried blood spot samples shall only be used as an alternative means of specimen collection where there is difficulty in extracting blood (e.g. very young infants, no medical technologist or certified phlebotomist), maintaining the specimen at 2-8°C during storage and transport (i.e. selected island barangays, municipalities or RHUs, and provinces, lack of specimen storage facilities and no local courier). Collection shall be done by medical, paramedical and other trained personnel (doctors, medical technologists, nurses, midwives, etc).
3. Use of Oropharygeal and/or Nasopharyngeal swab for virus isolation
To monitor transmission pathways of measles virus during outbreaks, it is important to collect sample for viral isolation and characterization. Oropharyngeal and Nasopharyngeal swab (OPS/NPS) are the most appropriate specimens for virus isolation, OPS/NPS shall be collected as soon as possible within five (5) days of rash onset from any cluster of suspected measles cases. The probability that the measles virus can be isolated is highest during the first 3 days of rash onset.
In collecting NPS, the response team shall consider the guide below in collecting samples of cases in a cluster/ outbreak:• 3 cases - collect at least 1-2 samples
• 5 cases - collect a minimum of 3 samples
• 10 cases – collect a minimum of 5 samples
• >10 or more cases - collect a minimum of 10 samples
Viral isolation is significant to confirm whether the transmissions of indigenous measles strains have been fully eliminated or not. This will certify if the country has achieved the measles elimination goal.
Single or sporadic measles case with history of travel or unknown history of travel shall be collected with samples for both IgM testing (eg. Serum or DBS) and viral isolation (NPS) to determine transmission pathway and differentiate between importation and indigenous transmission.
B. Roles and Responsibilities1. Research Institute for Tropical Medicine
a. Shall receive all specimens from the DRUs and other allied health units
b. Shall inform the RESU if specimen/s arrives at RITM in bad condition and if recollection is needed
c. Shall process/test the specimens and send timely result to National Epidemiology Center (NEC), National Center for Disease and Prevention Control (NCDPC) and RESUs
d. Shall build and develop laboratory capacity and networking of laboratories at the national and local levels if needed
e. Shall collaborate with WHO to strengthen molecular surveillance and virus identification and share laboratory results (both serology and virus identification) on a monthly basis with WHO country office
2. National Epidemiology Center
a. Shall over see the over-all implementation of high quality measles surveillance in all regions, province and cities
b. Shall monitor and provide technical support to all regions, provinces and cities that are experiencing low surveillance performance
c. Shall facilitate the provision of logistics for specimen collection to All RESUs
d. Shall facilitate/ensure transport of specimens from the RESU/PESU and RHU
e. Shall ensure the adequacy & timeliness of specimen collected
f. Shall perform the overall coordination and data management
3. Center for Health development
a. Shall coordinate and investigate suspect measles cases
b. Shall monitor and provide technical support to all provinces and cities that are experiencing low surveillance performance
c. Shall be responsible for regional level surveillance data management
d. Shall ensure the proper and timely collection, storage and transport of specimens to the National Measles Reference Laboratory (e.g. RITM)
e. Shall facilitate the provision of logistics to the hospitals and LGUs
f. Shall send laboratory results to concerned LGUs
4. PESU/PHO/RHU
a. Shall coordinate the reporting and investigation of suspect measles cases
b. Shall be responsible for provincial/city level surveillance data management
c. Shall ensure the proper and timely collection, storage and transport of specimens to the national reference laboratory, RITM and or CHD
d. Shall facilitate the provision of logistics to the hospitals and LGUs
e. Shall ensure that CIFs are completely filled up sealed in a separate plastic bag and enclosed in the shipping box
f. Shall send laboratory results to concerned LGUs
5. All Hospitals
a. All suspected measles cases in-patient and out-patient wards shall be completely investigated with proper documentation
b. Shall collect blood specimen for all suspected measles cases at first contact or within 28 days from rash onset following the standard procedure in specimen collection
c. Shall properly label, store and/transport blood specimens to ESU/RITM
d. Shall ensure that CIFs are completely filled up sealed in a separate plastic bag and enclosed in the shipping box
e. Shall keep specimen collection kits properly and check for the expiration date
f. Shall coordinate with CHD/ESU for the laboratory results
C. Funding Requirements
Budgetary requirements such as laboratory expenses, logistic support and other laboratory requirements for testing shall be charged against the Research Institute for Tropical Medicine through the support of department of Health and World Health Organization. The freight and handling of specimen shall be charged against the different CHDs, subject to the usual accounting and auditing rules and regulations.